Life AI Net
Inicio
Archivo
Calculadoras
Directorio
Boletín
Hot
Iniciar sesión
Español
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Inicio
Archivo
Calculadoras
Directorio
Boletín
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Iniciar sesión
Inicio
Archivo
Calculadoras
Directorio
More
En vivo
FierceBiotech
Replimmune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection
10x Genomics Blog
10x Genomics debuts Atera, a new platform to redefine how biology is measured and understood at AACR 2026 - SelectScience
Illumina
Clinical Genomic Market: Growth and Outlook Driven by Illumina, - openPR.com
Thermo Fisher
Assessing Thermo Fisher Scientific (TMO) Valuation After New PCR Launch And Data Partnerships - simplywall.st
Curiosis Inc.
Working capital per share of Curiosis, Inc. – KRX:494120 - TradingView
Waters
Waters Corporation Schedules First Quarter 2026 Earnings Conference Call - ChartMill
Lonza News
Lonza Group AG stock (CH0013841017): Is its biopharma contract focus strong enough to unlock new ups - AD HOC NEWS
Cell
B cell deficiency limits exercise capacity by remodeling liver glutamate metabolism
Cell
A phytoscreen identifies a garlic compound as a deterrent of mating and egg laying in <em>Drosophila</em> and mosquitoes
Cell
p53 safeguards chemical reprogramming of human somatic cells toward pluripotency
Cell
2'3'-cGAMP-induced membrane shearing promotes broad antiphage immunity
Cell
Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade
FierceBiotech
Replimmune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection
10x Genomics Blog
10x Genomics debuts Atera, a new platform to redefine how biology is measured and understood at AACR 2026 - SelectScience
Illumina
Clinical Genomic Market: Growth and Outlook Driven by Illumina, - openPR.com
Thermo Fisher
Assessing Thermo Fisher Scientific (TMO) Valuation After New PCR Launch And Data Partnerships - simplywall.st
Curiosis Inc.
Working capital per share of Curiosis, Inc. – KRX:494120 - TradingView
Waters
Waters Corporation Schedules First Quarter 2026 Earnings Conference Call - ChartMill
Lonza News
Lonza Group AG stock (CH0013841017): Is its biopharma contract focus strong enough to unlock new ups - AD HOC NEWS
Cell
B cell deficiency limits exercise capacity by remodeling liver glutamate metabolism
Cell
A phytoscreen identifies a garlic compound as a deterrent of mating and egg laying in <em>Drosophila</em> and mosquitoes
Cell
p53 safeguards chemical reprogramming of human somatic cells toward pluripotency
Cell
2'3'-cGAMP-induced membrane shearing promotes broad antiphage immunity
Cell
Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade
Archivo
Buscar
Buscar
Reciente
Más antiguo
Borrar
@BioWorld
Total
1053
Fuente
BioWorld
Búsqueda
--
BioWorld
30 mar 2026
Rapt Therapeutics synthesizes new TNF-α modulators
BioWorld
30 mar 2026
Ventus Therapeutics patents caspase-4/5 inhibitors
BioWorld
30 mar 2026
Nanjing Sanhome Pharmaceutical discloses new WRN inhibitors
BioWorld
30 mar 2026
Sichuan Kelun-Biotech identifies new glucocorticoid receptor agonists
BioWorld
27 mar 2026
Biopharma money raised: Jan. 1-March 26, 2026
BioWorld
27 mar 2026
Money raised by biopharma
BioWorld
27 mar 2026
Regulatory actions for March 27, 2026
BioWorld
27 mar 2026
Phase III wins lift shares of Compass, Palvella and Bridgebio in February
BioWorld
27 mar 2026
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld
27 mar 2026
Korea roundup: Alteogen, Celltrion lead biotech deals
BioWorld
27 mar 2026
FDA approves Rocket’s Kresladi as first gene therapy for LAD-I
BioWorld
27 mar 2026
Shanghai Institute of Materia Medica discloses new GLP-1R agonists
BioWorld
27 mar 2026
Aconcagua Bio synthesizes new calcitonin and amylin receptor agonists
BioWorld
27 mar 2026
Sichuan University reports new GPR65 antagonists
BioWorld
27 mar 2026
Chengdu Sibeibo divulges new PARP-14 inhibitors
BioWorld
27 mar 2026
Pinnacle raises an $89M series B for its oral peptide programs
BioWorld
26 mar 2026
Financings for March 26, 2026
BioWorld
26 mar 2026
In the clinic for March 26, 2026
Anterior
9 / 59
Siguiente